Acuitas Investments, LLC Lumos Pharma, Inc. Transaction History

Acuitas Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$2.19 - $3.04 $1,633 - $2,267	746 Added 0.53%	141,435 $328,000
Q1 2024 May 10, 2024	BUY	$2.64 - $3.22 $40,674 - $49,610	15,407 Added 12.3%	140,689 $396,000
Q4 2023 Feb 02, 2024	BUY	$2.81 - $4.27 $112 - $170	40 Added 0.03%	125,282 $398,000
Q3 2023 Oct 27, 2023	SELL	$2.63 - $3.49 $75,283 - $99,901	-28,625 Reduced 18.6%	125,242 $413,000
Q2 2023 Aug 07, 2023	BUY	$3.01 - $4.38 $463,139 - $673,937	153,867 New	153,867 $507,000

2.2M

Ticker LUMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,396,070
Market Cap $36.4M
Description
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...

Get notified when there are updates to the investment portfolio of Acuitas Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuitas Investments, LLC with notifications on news.